Estradiol (tablet)
استرادیول (قرص)
🚻 Genito Urinary System And Sex HormonesOestrogen
Market / country: 🇺🇸 USA
Estrace (US) · Progynova (GB)
🧮 Dose calculator
Menopausal vasomotor symptoms · Regimen source: FDA Estradiol tablets · Dosage and Administration
- • Adjust to control symptoms, down to the lowest maintenance dose; add a progestin if the uterus is intact. FDA Estradiol tablets · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Undiagnosed genital bleeding; breast or oestrogen-dependent cancer; DVT/PE or arterial thrombosis; liver disease; pregnancy. FDA Premarin · 4
Warnings
- • Boxed warning: endometrial cancer (unopposed oestrogen with a uterus), cardiovascular disorders, breast cancer and probable dementia; lowest dose, shortest time. FDA Premarin · Boxed Warning
Formulations
- 0.5 mg tablet (scored) — tablet 🇺🇸 USA FDA Estradiol tablets · How Supplied
- 1 mg tablet (scored) — tablet 🇺🇸 USA FDA Estradiol tablets · How Supplied
- 2 mg tablet (scored) — tablet 🇺🇸 USA FDA Estradiol tablets · How Supplied
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Estradiol tablets · CONTRAINDICATIONS
“Known or suspected pregnancy.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Estradiol tablets · Precautions/Warnings – Nursing Mothers
“Caution should be exercised when estradiol is administered to a nursing woman.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Estradiol tablets · Precautions/Warnings – Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Estradiol tablets · Boxed Warning
“The Women’s Health Initiative Memory Study (WHIMS), a substudy of WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with oral conjugated estrogens plus medroxyprogesterone acetate relative to placebo.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA040275
- DailyMed (FDA label)FDA Estradiol tabletsFDA Premarin
- MedlinePlus (NIH)Estradiol TopicalEstradiol Transdermal Patch
- WHO ATC/DDDG03CA03
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Estradiol tablets · How SuppliedFDA Estradiol tablets · Dosage and AdministrationFDA Premarin · 4FDA Premarin · Boxed WarningFDA Estradiol tablets · CONTRAINDICATIONSFDA Estradiol tablets · Precautions/Warnings – Nursing MothersFDA Estradiol tablets · Precautions/Warnings – Pediatric UseFDA Estradiol tablets · Boxed WarningFDA Estradiol tablets · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified